Activity of Inflammatory Bowel Disease After Liver Transplantation for Primary Sclerosing Cholangitis Predicts Poorer Clinical Outcomes
The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
Background: The impact of inflammatory bowel disease (IBD) activity on long-term outcomes after liver transplantation (LT) for primary sclerosing cholangitis (PSC) is unknown. We examined the impact of post-LT IBD activity on clinically significant outcomes. Methods: One hundred twelve patients undergoing LT for PSC from 2 centers were studied for a median of 7 years. Patients were divided into 3 groups according to their IBD activity after LT: no IBD, mild IBD, and moderate to severe IBD. Patients were classified as having moderate to severe IBD if they met at least 1 of 3 criteria: (i) Mayo 2 or 3 colitis or Simple Endoscopic Score–Crohn’s Disease ≥7 on endoscopy; (ii) acute flare of IBD necessitating steroid rescue therapy; or (iii) post-LT colectomy for medically refractory IBD. Results: Moderate to severe IBD at any time post-transplant was associated with a higher risk of Clostridium difficile infection (27% vs 8% mild IBD vs 8% no IBD; P = 0.02), colorectal cancer/high-grade dysplasia (21% vs 3% both groups; P = 0.004), post-LT colectomy (33% vs 3% vs 0%) and rPSC (64% vs 18% vs 20%; P < 0.001). Multivariate analysis revealed that moderate to severe IBD increased the risk of both rPSC (relative risk [RR], 8.80; 95% confidence interval [CI], 2.81–27.59; P < 0.001) and colorectal cancer/high-grade dysplasia (RR, 10.45; 95% CI, 3.55–22.74; P < 0.001). Conclusions: Moderate to severe IBD at any time post-LT is associated with a higher risk of rPSC and colorectal neoplasia compared with mild IBD and no IBD. Patients with no IBD and mild IBD have similar post-LT outcomes. Future prospective studies are needed to determine if more intensive treatment of moderate to severe IBD improves long-term outcomes in patients undergoing LT for PSC.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Also, chronic inflammation in IBD is associated with increased risk for colorectal malignancy.359,[369][370][371]”
From EASL Clinical Practice Guidelines on sclerosing cholangitis (2022) · cites this paper as [369]
In the citing paper
“Higher inflammatory activity of IBD after liver transplantation has also been shown to increase the risk for recurrent PSC and colorectal cancer.369”
From EASL Clinical Practice Guidelines on sclerosing cholangitis (2022) · cites this paper as [369]
Citations
Cites
Satsangi, J., Silverberg, M. S., Vermeire, S., & Colombel, J.-F. (2006) · Gut · doi:10.1136/gut.2005.082909 · Cited by 3,176
Banff Schema for Grading Liver Allograft Rejection: An International Consensus Document
Demetris, A. J., Batts, K. P., Dhillon, A. P., Ferrell, L., Fung, J., Geller, S. A., Hart, J., Hayry, P., Hofmann, W. J., Hubscher, S., et al. (1997) · Hepatology · doi:10.1002/hep.510250328 · Cited by 1,272
Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis
Rutter, M., Saunders, B., Wilkinson, K., Rumbles, S., Schofield, G., Kamm, M., Williams, C., Price, A., Talbot, I., & Forbes, A. (2004) · Gastroenterology · doi:10.1053/j.gastro.2003.11.010 · Cited by 1,255
Watt, K. D. S., Pedersen, R. A., Kremers, W. K., Heimbach, J. K., & Charlton, M. R. (2010) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2010.03126.x · Cited by 785
PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis
Loftus, E. V., Harewood, G. C., Loftus, C. G., Tremaine, W. J., Harmsen, W. S., Zinsmeister, A. R., Jewell, D. A., & Sandborn, W. J. (2005) · Gut · doi:10.1136/gut.2004.046615 · Cited by 777
Soetikno, R. M., Lin, O. S., Heidenreich, P. A., Young, H. S., & Blackstone, M. O. (2002) · Gastrointestinal Endoscopy · doi:10.1067/mge.2002.125367 · Cited by 623
Recurrence of Primary Sclerosing Cholangitis Following Liver Transplantation
Graziadei, I. W., Wiesner, R. H., Batts, K. P., Marotta, P. J., LaRusso, N. F., Porayko, M. K., Hay, E. J., Gores, G. J., Charlton, M. R., Ludwig, J., et al. (1999) · Hepatology · doi:10.1002/hep.510290427 · Cited by 375
Long-term results of patients undergoing liver transplantation for primary sclerosing cholangitis
Graziadei, I. W., Wiesner, R. H., Marotta, P. J., Porayko, M. K., Hay, E. J., Charlton, M. R., Poterucha, J. J., Rosen, C. B., Gores, G. J., LaRusso, N. F., et al. (1999) · Hepatology · doi:10.1002/hep.510300501 · Cited by 359
Brentnall, T., Haggitt, R., Rabinovitch, P., Kimmey, M., Bronner, M., Levine, D., Kowdley, K., Stevens, A., Crispin, D., Emond, M., et al. (1996) · Gastroenterology · doi:10.1053/gast.1996.v110.pm8566577 · Cited by 337
Addolorato, G., Capristo, E., Stefanini, G. F., & Gasbarrini, G. (1997) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529709011218 · Cited by 242
Cited by
EASL Clinical Practice Guidelines on sclerosing cholangitis
Chazouilleres, O., Beuers, U., Bergquist, A., Karlsen, T. H., Levy, C., Samyn, M., Schramm, C., & Trauner, M. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2022.05.011 · Cited by 419
EASL Clinical Practice Guidelines on liver transplantation
Samuel, D., De Martin, E., Berg, T., Berenguer, M., Burra, P., Fondevila, C., Heimbach, J. K., Pageaux, G.-P., Sanchez-Fueyo, A., & Toso, C. (2024) · Journal of Hepatology · doi:10.1016/j.jhep.2024.07.032 · Cited by 263
The microbiota and the gut–liver axis in primary sclerosing cholangitis
Hov, J. R., & Karlsen, T. H. (2022) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-022-00690-y · Cited by 139
Inflammatory bowel disease and primary sclerosing cholangitis: One disease or two?
van Munster, K. N., Bergquist, A. M., & Ponsioen, C. Y. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2023.09.031 · Cited by 139
Trivedi, P. J., Hirschfield, G. M., Adams, D., & Vierling, J. M. (2024) · Gastroenterology · doi:10.1053/j.gastro.2024.01.049 · Cited by 112
Carbone, M., Penna, A. D., Mazzarelli, C., Martin, E. D., Villard, C., Bergquist, A. M., Line, P., Neuberger, J., Al-Shakhshir, S., Trivedi, P. J., et al. (2023) · Transplant International · doi:10.3389/ti.2023.11729 · Cited by 62
Quraishi, M. N., Cheesbrough, J., Rimmer, P. J., Mullish, B. H., Sharma, N. K., Efstathiou, E., Acharjee, A., Gkoutus, G., Patel, A. M., Marchesi, J. R., et al. (2024) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjae189 · Cited by 45
Te, H. S., Agopian, V. G., Demetris, A. J., Kwo, P. Y., McGuire, B. M., Russo, M. W., Selzner, N., Washburn, W. K., Winder, G. S., & Schiano, T. D. (2025) · Liver Transplantation · doi:10.1097/lvt.0000000000000715 · Cited by 42
Role of microbiome in autoimmune liver diseases
Schneider, K. M., Kummen, M., Trivedi, P. J., & Hov, J. R. (2023) · Hepatology · doi:10.1097/hep.0000000000000506 · Cited by 40
Crothers, H., Ferguson, J., Quraishi, M. N., Cooney, R. M., Iqbal, T. H., & Trivedi, P. J. (2024) · The Lancet Regional Health - Europe · doi:10.1016/j.lanepe.2024.101002 · Cited by 31
Liver transplantation for cholestatic liver diseases: Timing and disease recurrence
Cançado, G. G. L., Deeb, M., & Gulamhusein, A. F. (2025) · Hepatology · doi:10.1097/hep.0000000000001268 · Cited by 24
Chrisinger, J. S. A., Dassopoulos, T., Yan, Y., & Nalbantoglu, I. (2020) · World Journal of Gastroenterology · doi:10.3748/wjg.v26.i28.4126 · Cited by 24
Åberg, F. O., Sallinen, V. J., Tuominen, S., Adam, R. A., Karam, V. H., Mirza, D. F., Heneghan, M. A., Line, P., Bennet, W., Ericzon, B., et al. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2023.08.031 · Cited by 22
Roth, D., Düll, M. M., Horst, L. J., Lindemann, A., Malzer, X., Koop, K., Zundler, S., Vetter, M., Jefremow, A., Atreya, R. N., et al. (2024) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjae131 · Cited by 18
Kulkarni, C. V., Murag, S., Cholankeril, G. T., Fardeen, T., Mannalithara, A., Lerrigo, R., Kamal, A., Ahmed, A., Goel, A., & Sinha, S. R. (2020) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izaa317 · Cited by 17
Ribaldone, D. G., Imperatore, N., Grazie, M. L., Furfaro, F., Balestrieri, P., BLASIO, F. D., Fagoonee, S., Mosso, E., Boano, V., Reggio, D., et al. (2020) · Digestive and Liver Disease · doi:10.1016/j.dld.2020.09.011 · Cited by 16
Recurrent Primary Sclerosing Cholangitis: Current Understanding, Management, and Future Directions
Leung, K. K., Deeb, M., Fischer, S. E., & Gulamhusein, A. F. (2021) · Seminars in Liver Disease · doi:10.1055/s-0041-1730950 · Cited by 12
Henson, J. B., & King, L. Y. (2023) · Clinics in Liver Disease · doi:10.1016/j.cld.2023.07.009 · Cited by 12
Catanzaro, E., Gringeri, E., Cazzagon, N., Floreani, A., Cillo, U., Burra, P., & Gambato, M. (2024) · Journal of Personalized Medicine · doi:10.3390/jpm14030222 · Cited by 11
Coelho–Prabhu, N., Ohri, A., Benatzky, C., Baskaran, N. U., Eaton, J. E., Lazaridis, K. N., Pratt, D., & Ananthakrishnan, A. N. (2025) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2025.02.024 · Cited by 9
Autorinnen/Autoren, & Collaborators (2025) · Zeitschrift für Gastroenterologie · doi:10.1055/a-2558-5204 · Cited by 10
Schabl, L., Holubar, S. D., Maspero, M., Steele, S. R., & Hull, T. L. (2024) · Techniques in Coloproctology · doi:10.1007/s10151-024-02976-6 · Cited by 10
Andishgar, A., Bazmi, S., Lankarani, K. B., Taghavi, S. A., Imanieh, M. H., Sivandzadeh, G., Saeian, S., Dadashpour, N., Shamsaeefar, A., Ravankhah, M., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-89570-4 · Cited by 9
Sleiman, J., Francis, F. F., Coelho–Prabhu, N., & Hashash, J. G. (2025) · Annals of Gastroenterology · doi:10.20524/aog.2025.0945 · Cited by 9
Dunleavy, K. A., Santiago, P., Forde, G., Harmsen, W. S., McKenna, N. P., Coelho–Prabhu, N., Shawki, S. F., & Raffals, L. E. (2023) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izad278 · Cited by 8
Chin, S., Con, D., Hilley, P., Corte, C., Liu, K., Testro, A., Cruz, P. P. D., Choy, M. C., & Srinivasan, A. R. (2025) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.70283 · Cited by 8
Patel, M. J., Zhang, B. Y., Cotter, T. G., & Anouti, A. (2024) · Journal of Liver Transplantation · doi:10.1016/j.liver.2024.100244 · Cited by 5
Treatment of Primary Sclerosing Cholangitis Including Transplantation
Wheless, W. H., & Russo, M. W. (2023) · Clinics in Liver Disease · doi:10.1016/j.cld.2023.07.008 · Cited by 5
Vorasittha, A., Sakamoto, S., Yanagi, Y., Degawa, K., Kato, H., Kodama, T., Komine, R., Yamada, M., Uchida, H., Fukuda, A., et al. (2025) · Pediatric Transplantation · doi:10.1111/petr.70078 · Cited by 4
de Jong, M. J., Zhou, J., Derikx, L. A. A. P., Murad, S. D., van der Meer, A. J., & de Vries, A. C. (2026) · Transplantation · doi:10.1097/tp.0000000000005607 · Cited by 4
Distinct phenotype of primary sclerosing cholangitis-associated inflammatory bowel disease
Okada, H., Sugimoto, S., Kayashima, A., Mikami, Y., Kanai∥, T., Nakamoto, N., Collaborators, K. P., Yoshimatsu, Y., Kiyohara, H., Nakadai, Y., et al. (2026) · Journal of Gastroenterology · doi:10.1007/s00535-026-02388-3 · Cited by 4
Vitor, I. C., Tomé, M. R., Amador, W. F. O., Silveira, I. B., Leite, M. D. A. B. C., Passos, P. R. C., Filho, V. O. C., Noronha, M. M., Rossi, Y. I., Cançado, G. G. L., et al. (2026) · Liver International · doi:10.1111/liv.70673 · Cited by 3
Bastón‐Rey, I., Rodríguez–Lago, I., Luque, A. M., Caballol, B., Soutullo, C., Bravo, A., Castaño, A., Gros, B., Bernal, L., Diz-Lois, M. T., et al. (2024) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izae041 · Cited by 3
Polanco, N. A. P., Cottone, C., & Bhamidimarri, K. R. (2020) · Current Hepatology Reports · doi:10.1007/s11901-020-00518-w · Cited by 4
Ar, E., Solomonidou, I., Lenzen, H., Wiestler, M., Veltkamp, C., Willuweit, K., Rashidi‐Alavijeh, J., Schmidt, H., Vollenberg, R., Tepasse, P., et al. (2026) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izaf330 · Cited by 2
Sebode, M., Bantel, H., Baumann, U., Bufler, P., Demir, M., Dold, L., Keitel, V., Klein, R., Kremer, A. E., Jansen, P. L., et al. (2026) · Zeitschrift für Gastroenterologie · doi:10.1055/a-2769-2475 · Cited by 2
Wong, Y. J., Kew, G. S., & Montaño‐Loza, A. J. (2026) · Clinics in Liver Disease · doi:10.1016/j.cld.2026.04.012 · Cited by 1
Primary Sclerosing Cholangitis
Hussain, N., & Trivedi, P. J. (2026) · Clinics in Liver Disease · doi:10.1016/j.cld.2026.04.013 · Cited by 1
Peverelle, M., Cruz, P. P. D., Paleri, S., & Gow, P. J. (2021) · Liver Transplantation · doi:10.1002/lt.26009 · Cited by 1
Self-citationLiver Transplantation and Inflammatory Bowel Disease: Breaking Barriers in a Low‐Income Country
Kauffman‐Ortega, E., Ruiz-Manríquez, J. A., Olivas‐Martínez, A., Campos-Murguía, A., Márquez-Guillén, E., Flores-García, N. C., Vilatobá, M., Contreras, A. G., & García‐Juárez, I. (2020) · Liver Transplantation · doi:10.1002/lt.25928
Aziz, B. (2021) · ERA: Education and Research Archive (University of Alberta) · doi:10.7939/r3-vrjm-2y91
Liver Disease in Pediatric Inflammatory Bowel Disease
Little, R., Kamath, B. M., & Ricciuto, A. (2023) · Springer eBooks · doi:10.1007/978-3-031-14744-9_11
Primary Sclerosing Cholangitis and Inflammatory Bowel Disease
Escobar, J. C., Pereyra, M. N., & Abbass, M. A. (2025) · Surgical Clinics of North America · doi:10.1016/j.suc.2024.11.001
Natt, N., May, T. J., Malhi, G., Dumond, J., Gulamhusein, A. F., & Tandon, P. (2025) · Journal of the Canadian Association of Gastroenterology · doi:10.1093/jcag/gwaf023
Ar, E., Solomonidou, I., Lenzen, H., Wiestler, M., Veltkamp, C., Willuweit, K., Rashidi‐Alavijeh, J., Schmidt, H., Vollenberg, R., Tepasse, P., et al. (2025) · Biomedicines · doi:10.3390/biomedicines13092200
Interpreting surgical associations in primary sclerosing cholangitis: Caution in clinical messaging
Mol, B., & Trivedi, P. J. (2026) · Hepatology · doi:10.1097/hep.0000000000001766
Features of the course and therapeutic strategy of ulcerative colitis in liver transplant recipients
Smirnova, T. O., Евгеньевич, С. В., Parinov, O. V., & Voskanyan, S. E. (2026) · Экспериментальная и клиническая гастроэнтерология · doi:10.31146/1682-8658-ecg-246-2-61-83
Kaur, A., Mody, S., Chernet, R. L., Chaar, A., Nawaz, A., Shah, A., Subedi, A., John, S., & Goren, I. (2026) · Therapeutic Advances in Gastroenterology · doi:10.1177/17562848261497855
Zhou, J., Sneek, D., Hansen, B. E., den Hoed, C. M., de Jong, M. J., van der Meer, A. J., Pan, Q., Li, P., & de Vries, A. C. (2026) · Transplantation · doi:10.1097/tp.0000000000005894
Metadata
- Authors
- Peverelle, M., Paleri, S., Hughes, J., De Cruz, P., & Gow, P. J.
- Affiliations
- Liver Transplant Unit, Heidelberg, Victoria, Australia
- Department of Gastroenterology, Austin Health, Heidelberg, Victoria, Australia
- The University of Melbourne (AU)
- Venue
- Inflammatory Bowel Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2020-01-16
- Volume
- 26
- Issue
- 12
- Pages
- 1901-1908
- ISSN
- 1078-0998 (ISSN-L)
- 1536-4844
- OpenAlex
- W2999697863
- Cited by
- 47
- References
- 33
- Citations by year
- 2026: 11 · 2025: 9 · 2024: 9 · 2023: 8 · 2022: 2 · 2021: 3 · 2020: 5
- FWCI
- 2.65
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Locations
- Inflammatory Bowel Diseases (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Health Sciences › Medicine › Surgery › Organ Transplantation Techniques and Outcomes
- Keywords
- inflammatory bowel disease, primary sclerosing cholangitis
- MeSH terms
- Adult, Colectomy, Enterocolitis, Pseudomembranous, Female, Humans, Male, Middle Aged, Postoperative Complications, Postoperative Period, Recurrence, Registries, Risk Factors, Severity of Illness Index, Colorectal Neoplasms, Cholangitis, Sclerosing, Inflammatory Bowel Diseases, Multivariate Analysis, Liver Transplantation, Clostridioides difficile, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.